v pen 800 800000 iu tablet - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

gapentin gabapentin 800 mg tablet blister pack

arrotex pharmaceuticals pty ltd - gabapentin, quantity: 800 mg - tablet, film coated - excipient ingredients: magnesium stearate; copovidone; purified talc; hyprolose; poloxamer; maize starch - gapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults who have not achieved adequate control with standard antiepileptic drugs. gapentin is indicated for the treatment of neuropathic pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

apo-gabapentin gabapentin 800mg tablets bottle

arrotex pharmaceuticals pty ltd - gabapentin, quantity: 800 mg - tablet, film coated - excipient ingredients: copovidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; hyprolose - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. gabapentin is indicated for the treatment of neuropathic pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

ozvir aciclovir 800mg tablet blister pack

sun pharma anz pty ltd - aciclovir, quantity: 800 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica - aciclovir tablets are indicated for use in adult patients for: (1) the treatment of first episode (primary or non-primary) genital herpes and the management of recurrent episodes of genital herpes in certain patients. (2) the treatment of acute attacks of herpes zoster (shingles) when the duration of rash is less than 72 hours. (3) the management of patients with advaned symptomatic hiv disease cd4 + counts < 150 x 10(6)/l). in accordance with details specified in the "indications" and the "dosage and administration" sections of the approved product information provided as attachment 1.